Here's What to Expect from STERIS’ Next Earnings Report

Mentor, Ohio-based STERIS plc (STE) provides infection prevention products and services worldwide. With a market cap of $20.3 billion, STERIS operates through Healthcare, Applied Sterilization Technologies (AST), and Life Sciences segments. The healthcare major is expected to announce its third-quarter earnings on Wednesday, Feb. 5.

Ahead of the event, analysts expect STERIS to report a non-GAAP profit of $2.32 per share, up 4.5% from $2.22 per share reported in the year-ago quarter. Furthermore, the company has surpassed or matched Wall Street’s bottom-line projections in each of the past four quarters. Its adjusted EPS for the last reported quarter increased 5.4% year-over-year to $2.14, exceeding analysts’ estimates by 1.4%.